2026-09-22 · Sinophare Editorial Team
Supply security starts with production capacity.
Sinophare Biotechnology operates standardized GMP workshops across three formulation platforms. Our sterile lines output 300 million ampoule injections (1ml, 2ml, 3ml, 5ml), 100 million IV infusion bottles (100ml, 500ml, 1000ml) and 50 million eye-drop pieces (5ml, 10ml) every year.
For solid orals, we produce 2 billion tablets and 1 billion capsules annually, plus 50 million granule and powder sachets. On the API side, paracetamol reaches 5,000 tons per year, with ceftriaxone sodium and sterile cephalosporin powders completing the portfolio.
What does this mean for distributors? Predictable lead times, sufficient safety stock on regular items, and batch-level traceability under full GMP quality control. Contact our export team for the capacity plan of your target products.
Sinophare Biotech